LEXARIA BIOSCIENCE CORP. Cash and Restricted Cash
LEXARIA BIOSCIENCE CORP. (LEXX) had Cash and Restricted Cash of $3.48 million as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-13
- 2026-05-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.48M.
- 2026-02-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.13M.
- 2025-11-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.28M.
- 2025-08-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.80M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-05-31 | $3.48M 10-Q · filed 2026-07-13 |
| 2026-02-28 | $5.13M 10-Q · filed 2026-04-13 |
| 2025-11-30 | $4.28M 10-Q · filed 2026-01-13 |
| 2025-08-31 | $1.80M 10-Q · filed 2026-07-13 |
| 2025-05-31 | $4.59M 10-Q · filed 2026-07-13 |
| 2025-02-28 | $6.47M 10-Q · filed 2026-04-13 |
| 2024-11-30 | $8.08M 10-Q · filed 2026-01-13 |
| 2024-08-31 | $6.50M 10-Q · filed 2026-07-13 |
| 2024-05-31 | $8.46M 10-Q · filed 2025-07-14 |
| 2024-02-29 | $4.71M 10-Q · filed 2025-04-14 |
| 2023-11-30 | $1.95M 10-Q · filed 2025-01-10 |
| 2023-08-31 | $1.35M 10-K · filed 2025-11-28 |
| 2023-05-31 | $3.16M 10-Q · filed 2024-07-12 |
| 2023-02-28 | $3.27M 10-Q · filed 2024-04-09 |
| 2022-11-30 | $4.53M 10-Q · filed 2024-01-12 |
| 2022-08-31 | $5.81M 10-K · filed 2024-11-26 |
| 2022-05-31 | $7.05M 10-Q · filed 2023-07-14 |
| 2022-02-28 | $8.36M 10-Q · filed 2023-04-14 |
| 2021-11-30 | $9.68M 10-Q/A · filed 2023-01-18 |
| 2021-08-31 | $10.92M 10-K · filed 2023-11-20 |
| 2020-08-31 | $1.29M 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |